Molecular Formula: C
22H
26ClN
7O
2S
Molecular Weight: 488.00554
InChIKey: ZBNZXTGUTAYRHI-UHFFFAOYSA-N
Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). The main targets of Dasatinib, are BCRABL, SRC, Ephrins and GFR.
From: DrugBank